Autologous epidermal sheets production for skin cellular therapy

Cell therapy is becoming a very interesting solution to replace degenerated or damaged tissues. In January 1998, Genevrier Laboratories inaugurated a new department especially designed for the production of cultured cells as therapeutic agents. Meeting clinician therapeutic needs by providing autolo...

Full description

Saved in:
Bibliographic Details
Published in:Annales pharmaceutiques françaises Vol. 61; no. 3; p. 203
Main Author: Vacher, D
Format: Journal Article
Language:French
Published: France 01-05-2003
Subjects:
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cell therapy is becoming a very interesting solution to replace degenerated or damaged tissues. In January 1998, Genevrier Laboratories inaugurated a new department especially designed for the production of cultured cells as therapeutic agents. Meeting clinician therapeutic needs by providing autologous keratinocytes and chondrocytes in the near future, represents the primary aim of the Biotechnology department. Concrete cell-based products are already being used for the treatment of burns and cutaneous chronic wounds such as the EPIBASE graft, which corresponds to an epidermis sheet composed of cultured autologous keratinocytes.
ISSN:0003-4509